2 results
Approved WMORecruiting
•To compare progression-free survival (PFS) as assessed by blinded independent central review (BICR) between sacituzumab govitecan (SG) versus treatment of physician*s choice (TPC)Secondary Objectives:•To compare overall survival (OS) between the 2…
Approved WMORecruiting
This study aims to investigate if fluorescence guided surgery performed with SGM-101 can improve R0 resection rates and allows to find additional malignant tissue in locally advanced and recurrent rectal cancer, or to achieve a *positive* change in…